Market Data 
Markets
Replies to post #206032 on NorthWest Biotherapeutics Inc (NWBO)
12/31/18 12:43 PM
L P& company worked for 10+ years to discover/create/validate the mechanisms, processes and methods to make DCVax viable and everyone realize the potential disruption in the pharmaceutical industry. Everyone is trying to jump on the bandwagon. But, IMHO, Linda may have created a barrier of entry by extending the trial, increasing the results-- assuming of course dcvax-l is approved.
instead of ragging on Lp/NWBO managment 24/7 give credit were credit is due. When most BPs abandoned Dendritic Cell Vaccines, LP was hard at work...and still is. A "thank you" would be appropriate.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145723802
I’m very surprised this isn’t a sub penny stock at this point. I really believe there is a big chance L will never see approval...especially since LP now has even more millions to take out of the company for her own private interests...she can’t keep this company afloat once this money runs out this time. I think the end of this long journey is rapidly approaching...I just feel terrible it appears LL’s work has been so poorly managed by these people...we will see, good or bad, very soon...I imagine, once the check is in the mail. This has been one self-serving disaster that is truly circling the drain imho.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145729573
...I’ve have been investing in the market for 30 years, in biotech, have never seen such a blatant disregard for investors and self-serving manipulation...seriously...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145766441
I just don’t understand how the SEC allows this to continue if never unblinded, or unblinded, and PFS FAILED YEARS AGO and they knew about it and didn’t disclose it to investors.
Wholeheartedly agree...Ultraz
This drug is in phase one testing. Other drugs in the pipeline are either in pre-phase-1 development, in phase-1 or just completing phase 1. During phase 1 everything looks promising as testing is primarily concerned with safety. Only after phase 2, will there be any info one can base an investment decision on.
There are bunch of small startup bios that are now testing Dendritic Cell Vaccines. Why is that? It could be because the L P& company worked for 10+ years to discover/create/validate the mechanisms, processes and methods to make DCVax viable and everyone realize the potential disruption in the pharmaceutical industry. Everyone is trying to jump on the bandwagon. But, IMHO, Linda may have created a barrier of entry by extending the trial, increasing the results-- assumming of course dcvax-l is approved.
So, perhaps you may want to, instead of ragging on Lp/NWBO managment 24/7 give credit were credit is due. When most BPs abandoned Dendritic Cell Vaccines, LP was hard at work...and still is. A "thank you" would be appropriate.
